115 related articles for article (PubMed ID: 35305448)
21. Neuroprotective effects of Eucommia ulmoides Oliv. Bark on amyloid beta(25-35)-induced learning and memory impairments in mice.
Kwon SH; Lee HK; Kim JA; Hong SI; Kim SY; Jo TH; Park YI; Lee CK; Kim YB; Lee SY; Jang CG
Neurosci Lett; 2011 Jan; 487(1):123-7. PubMed ID: 20974223
[TBL] [Abstract][Full Text] [Related]
22. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
[TBL] [Abstract][Full Text] [Related]
23. Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease.
Foley AM; Ammar ZM; Lee RH; Mitchell CS
J Alzheimers Dis; 2015; 44(3):787-95. PubMed ID: 25362040
[TBL] [Abstract][Full Text] [Related]
24. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
Wang CM; Devries S; Camboni M; Glass M; Martin PT
Neurobiol Dis; 2010 Sep; 39(3):409-22. PubMed ID: 20493257
[TBL] [Abstract][Full Text] [Related]
25. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
26. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
27. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Zou L; Nagai T; Hiramatsu M; Ikejima T; Nabeshima T
Br J Pharmacol; 2009 Aug; 157(7):1270-7. PubMed ID: 19552690
[TBL] [Abstract][Full Text] [Related]
28. Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease.
Subash S; Braidy N; Essa MM; Zayana AB; Ragini V; Al-Adawi S; Al-Asmi A; Guillemin GJ
Nutrition; 2015 Jan; 31(1):223-9. PubMed ID: 25441596
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K
Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157
[TBL] [Abstract][Full Text] [Related]
30. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
Ju Y; Tam KY
Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
[TBL] [Abstract][Full Text] [Related]
31. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
32. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.
McManus MJ; Murphy MP; Franklin JL
J Neurosci; 2011 Nov; 31(44):15703-15. PubMed ID: 22049413
[TBL] [Abstract][Full Text] [Related]
33. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.
Garcia P; Youssef I; Utvik JK; Florent-Béchard S; Barthélémy V; Malaplate-Armand C; Kriem B; Stenger C; Koziel V; Olivier JL; Escanye MC; Hanse M; Allouche A; Desbène C; Yen FT; Bjerkvig R; Oster T; Niclou SP; Pillot T
J Neurosci; 2010 Jun; 30(22):7516-27. PubMed ID: 20519526
[TBL] [Abstract][Full Text] [Related]
34. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
[TBL] [Abstract][Full Text] [Related]
35. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
36. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
38. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Canas PM; Porciúncula LO; Cunha GM; Silva CG; Machado NJ; Oliveira JM; Oliveira CR; Cunha RA
J Neurosci; 2009 Nov; 29(47):14741-51. PubMed ID: 19940169
[TBL] [Abstract][Full Text] [Related]
39. The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.
Leggio GM; Catania MV; Puzzo D; Spatuzza M; Pellitteri R; Gulisano W; Torrisi SA; Giurdanella G; Piazza C; Impellizzeri AR; Gozzo L; Navarria A; Bucolo C; Nicoletti F; Palmeri A; Salomone S; Copani A; Caraci F; Drago F
Pharmacol Res; 2016 Apr; 106():10-20. PubMed ID: 26875816
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer's disease via activation of α7nAChR.
Chang KW; Zong HF; Rizvi MY; Ma KG; Zhai W; Wang M; Yang WN; Ji SF; Qian YH
Neurobiol Learn Mem; 2020 Feb; 168():107154. PubMed ID: 31904546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
